Introduction
The v-mos gene of the Moloney murine sarcoma virus is a potent oncogene, both in its ability to transform NIH3T3 cells (Blair et al., , 1981 Oskarsson et al., 1980) and its ability to induce ®brosarcomas in mice (Canaani et al., 1979) . The mos protein is a serinethreonine protein kinase (Maxwell and Arlinghaus, 1985; Paules et al., 1992; Singh et al., 1988) that plays an essential role in the maturation of oocytes, being required for the activation of maturation promoting factor (MPF) (Freeman et al., 1990; O'Keefe et al., 1989; Paules et al., 1992; Sagata et al., 1988 Sagata et al., , 1989a . MPF is a cell cycle regulatory activity, consisting of a protein kinase complex of cdc2 and cyclin B proteins, that is required for the transition through both meiosis and mitosis (Nurse, 1990) .
It has been shown that mos can phosphorylate and activate the MAP kinase kinase (MAPKK) (Nebreda and Hunt, 1993; Posada et al., 1993) , and that transformation by mos can lead to increased expression of c-fos and c-jun (Schonthal and Feramisco, 1990 ) and increased AP-1 activity (Liu et al., 1994) as well as Elk-1 transcription activity (Nebreda et al., 1993) . In addition, transformation of NIH3T3 cells with the v-mos oncogene leads to inappropriate expression of cell cycle components such as cyclins and cdc2 (Rhodes et al., unpublished) . For example, levels of cdc2 mRNA, cdc2 protein, and associated protein kinase activity, all of which are normally down-regulated in serum starved cells (Lee et al., 1988; Morla et al., 1989; Richter et al., 1991) are still expressed in serum starved v-mostransformed cells (Rhodes et al., unpublished) . cdc2 mRNA expression has been shown to be regulated, in part, by the E2F transcription factor (Dalton, 1992) . The transcription factor E2F activates the transcription of several genes required for DNA synthesis such as dihydrofolate reductase (DHFR), thymidine kinase (TK), and c-myc (Blake and Azizkahn, 1989; Dou et al., 1992; Mudryj et al., 1991; Yee et al., 1989) . Furthermore, E2F complexed with the retinoblastoma tumor suppressor gene product (Rb), or the Rb-related p130 protein, negatively regulates transcription Vairo et al., 1995; Weintraub et al., 1992) . These ®ndings suggest that E2F is involved in both the positive and negative regulation of cell cycle progression and DNA synthesis.
Therefore, we decided to investigate the regulation of E2F transcription factor complexes in v-mostransformed NIH3T3 cells to determine whether mos transformation could eect E2F-mediated gene transcription, in addition to the eects that had previously been shown for AP-1 (Liu et al., 1994; Mansour et al., 1994) . We found that v-mos-transformed cells displayed altered regulation of the cell cycle expression of E2F complexes compared to non-transformed controls. Serum starved, G1 arrested v-mos-transformants lacked expression of the G1-speci®c p130-E2F complex. In addition, they constitutively expressed two p107-E2F complexes that are normally only detected during Sphase. Both of these complexes contain cdk2, and either cyclin A or cyclin E, which are both being expressed simultaneously in these cells. The result of this altered complex expression led to a ®vefold increase in E2F-mediated transcriptional activation, as measured by a reporter construct. These alterations in E2F transcription activity, combined with activation of AP-1 presumably via the MAP kinase pathway, could contribute to the inappropriate expression of cell cycle regulated genes and therefore the altered growth characteristics and transformed phenotype in these cells.
Results

E2F complexes during the normal cell cycle in NIH3T3 cells
In order to establish the normal pattern of E2F DNA binding complexes during the cell cycle of mouse cells, an analysis of these complexes was performed with synchronous populations of NIH3T3 cells. As shown in Figure 1a , during quiescence and in G1, two distinct E2F DNA binding complexes were observed (Figure 1a , 0 ± 9 h). Based on previous studies, these bands most likely represent the G1-speci®c p130-E2F complex (Cobrinik et al., 1993) and uncomplexed free E2F (Bagchi et al., 1990) . However, as the cells entered Sphase the G1 complex disappeared and was replaced by a new complex with slightly slower mobility ( Figure 1a , 16 ± 32 h). In addition to E2F, this complex has been previously described to contain p107, cdk2, and cyclin A or cyclin E (Devoto et al., 1992; Lees et al., 1992) .
E2F complexes in v-mos-transformed cells
Transformation of NIH3T3 cells by the v-mos oncogene has been shown to result in an alteration of the expression of cyclin-cdk complexes during the cell cycle (Rhodes et al., unpublished) . It has been shown that deregulated expression of G1 cyclins stimulates the expression of E2F1 (Johnson et al., 1994) . Therefore, v-mos-transformed cells were examined for alterations in E2F binding activity. As shown in Figure 1b , serum starved v-mos-transformed cells appeared to have a deregulation of E2F DNA binding activity (Figure 1b , 422 mos ss and 121 mos ss). These cells did not contain any detectable amounts of the putative, G1-speci®c p130-E2F complex that was present in serum starved untransformed NIH3T3 cells (Figure 1b , NIH3T3 ss, 3 h). They did appear, however, to have a complex that had a similar mobility to the S-phase complex in untransformed NIH3T3 cells (Figure 1b NIH3T3 , 16 h). In addition, both 121 mos and 422 mos cells seemed to have very low levels of uncomplexed E2F compared to parental NIH3T3 cells.
We also analysed binding in v-H-ras-and tpr-mettransformed NIH3T3 cells to see whether the binding pattern observed in the v-mos-transformed cells was speci®c for mos or was a general feature of NIH3T3 transformation. While some S-phase complex was observed in serum starved v-H-ras-and tpr-mettransformed cells, a signi®cant amount of the G1-speci®c E2F protein complex was also observed. This was in contrast to the complete absence of this complex in the v-mos-transformed 121 mos and 422 mos cells (Figure 1b) .
In order to determine whether activation and expression of mos was sucient to induce deregulation of E2F complexes, an inducible mos system was used. NIH3T3 cells containing a zinc-inducible c-mos construct were serum starved in the presence or absence of zinc (Figure 1c ). Similar to the v-mostransformed cells (Figure 1b) , induction of c-mos expression during low serum, G1 arrest ( Figure 1c , lane 4) resulted in the inappropriate expression of the S-phase E2F complexes. As expected, expression of anti-sense c-mos had no eect on the regulation of E2F complexes (Figure 1c , lane 1 ± 2).
A general problem in working with transformed cells is that they are dicult to synchronize and arrest. As shown in Figure 1b , serum starved v-mos-transformed cells had a small fraction (12 ± 15%) of cells in S-phase as shown by both¯ow cytometric analysis (%S) and autoradiography following incorporation of [ 3 H]thymidine into DNA (% labeling index [LI] ). To investigate whether the elevation of S-phase complex observed in these serum starved cells was due to this fraction of cells in S-phase, we performed mixing experiments using G1 and S-phase extracts from normal NIH3T3 cells (Figure 1d ). When the percentage of the S-phase fraction was equal to 15%, approximately equivalent to the amount in the serum starved v-mos-transformed cells, the predominant complex seen was the G1-speci®c E2F protein complex, with only a small amount of S-phase complex detected (Figure 1d , lane 4). This was similar to the pattern observed in serum starved tpr-mettransformed NIH3T3 cells (Figure 1b) , but was not the same as that observed in serum starved v-mostransformed cells. In fact, a binding pattern that was similar to the serum starved v-mos-transformed cells was not reconstituted until the fraction of S-phase extract reached 90% (Figure 1d , lane 11). Therefore, it is not likely that the pattern of E2F binding complexes in serum starved v-mos-transformed cells was due to a failure of the cells to arrest in G1, since a mixture of protein extracts that was composed of 85% G1 and 15% S-phase cell extracts did not give the E2F binding pattern observed in these cells.
Although the E2F complex that was present in the serum starved v-mos-transformed cells resembled the complex in S-phase parental NIH3T3 cells, it was possible that this was a dierent E2F protein complex that migrated with a similar mobility. Previously, the S-phase E2F complex was shown to contain cyclin A, p107, and cdk2 proteins (Devoto et al., 1992) . To address this possibility, a supershift analysis was performed by the addition of either p107 or cdk2 antibodies to extracts from S-phase NIH3T3 cells and serum starved v-mos-transformed cells (Figure 2a ). The addition of p107 ( Figure 2a , lanes 2 and 5) and cdk2 ( Figure 2a , lanes 3 and 6) antibodies to extracts from both S-phase NIH3T3 cells and serum starved 121 mos cells led to a supershift of the E2F complex, indicating that the E2F complexes in both cells contained p107 and cdk2. However, in contrast to what was observed previously (Mudryj et al., 1991) , we did not observe a supershift of all of the E2F complexes from the Sphase NIH3T3 extract with the addition of a cyclin A antibody ( Figure 2b , lanes 2 and 6). Lees et al. have reported that in addition to the p107/cyclin A/cdk2/ E2F complex, another complex containing p107/cyclin 
E2F - 3) and serum starved 121 mos cell extracts (lanes 4 ± 7). Lanes 2 and 5 are E2F complexes supershifted with p107 antibody, and lanes 3 and 6 are E2F complexes supershifted with cdk2 antibody. Lane 7 is an E2F DNA binding assay performed with 121 mos extract containing a 100-fold excess cold probe. (b) Gel supershift analysis of E2F complexes from S-phase NIH3T3 extracts (lanes 1 ± 4) and serum starved 121 mos extracts (lanes 5 ± 8) supershifted with cyclin A antibody (lanes 2 and 6), cyclin E antibody (lanes 3 and 7), or both cyclin A and E antibodies, combined (lanes 4 and 8). Lanes 9 and 10 are control assays with antibodies and probe but no protein extract. (c) Coupled-immunoprecipitation gel shift of E2F complexes. E2F binding assay with proteins elute from deoxycholate-treated E/cdk2/E2F was observed in late G1 (Lees et al., 1992) . The addition of a cyclin E antibody also did not supershift the entire S-phase complex (Figure 2b , lanes 3 and 7). However, the addition of both cyclin antibodies to the extracts did result in a complete supershift of all of the E2F complexes from both the Sphase NIH3T3 and serum starved v-mos-transformed cell extracts (Figure 2b, lanes 4 and 8) . This indicated that the binding complex designated as the S-phase was composed of two similarly migrating complexes, a p107/cyclin E/cdk2 and p107/cyclin A/cdk 2 E2F complex. In addition, these two complexes that were observed during S-phase in untransformed NIH3T3 cells (Figure 1b , NIH3T3 16 h) were identical to the complexes present in serum starved v-mos-transformed cells (Figure 1b 422 mos, 121 mos ss). The presence of similar complex components in serum starved v-mos-transformed cells and S-phase NIH3T3 cells was con®rmed by immunoprecipitation of complexes with antibodies to complex components under non-denaturing conditions, followed by dissociation of the complexes by deoxycholate and then assaying for any precipitated E2F binding activity by gel shift analysis (Figure 2c ). E2F binding activity was immunoprecipitated from extracts from serum starved v-mos-transformed cells and S-phase NIH3T3 cells with cyclin A, cyclin E, p107, and cdk2 antibodies. No E2F DNA binding activity was associated with cyclin D, Rb, or p53. This method provided a more quantitative analysis than gel shift analyses for the amount of complexed E2F present in an extract. While the complex components were similar in serum starved vmos-transformed cells and S-phase NIH3T3 cells, the levels in the serum starved v-mos-transformed cells appeared to be slightly lower than those from S-phase NIH3T3 cells. This may indicate that there is a threshold level for the function of these complexes necessary to drive the cells into DNA synthesis.
Failure of E2F complexes to dissociate in v-mos transformants
Since v-mos-transformed cells arrested after serum starvation at a point in G1 that was dierent from the parental NIH3T3 cells (Rhodes et al., 1994) , it is possible that the reason the G1-speci®c E2F complex was not observed in the serum starved v-mostransformed cells was because the cells had traversed that phase of the cell cycle where this complex was assembled. Figure 3 shows the results of a cell synchronization experiment conducted to investigate this. Parental NIH3T3 cells and 121 mos cells were arrested in either G0 or early G1, respectively, by removing serum from the medium for 48 h. Cells were stimulated to reenter the cell cycle by the addition of medium containing 10% serum and aphidicolin. The aphidicolin was added to the medium so the cells renetering the cell cycle would arrest in early S-phase. After 16 h, the aphidicolin was removed, and cells were allowed to progress through the cell cycle for an additional 6 h, at which time the cells were either maintained in medium containing 10% serum and hence continued to cycle, or in medium again lacking serum to cause cells to reenter G0. DNA labeling indexes and¯ow cytometry analysis con®rmed that the cells were arrested and released appropriately (data not shown). This protocol allowed for cells to be followed through one complete round of the cell cycle and for the observation of how E2F complexes changed throughout. As was shown in Figure 1b 
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Figure 3 Cel synchrony and analysis of E2F complexes through the cell cycle. NIH3T3 (lanes 1 ± 4) and 121 mos (lanes 5 ± 8) cells were synchronized in G0 or early G1, respectively, by serum starvation (lanes 1 and 5). After 48 h, cells were refed with medium containing 10% serum and aphidicolin to arrest cells at G1/S (lanes 2 and 6). Cells were then washed and refed with complete medium for 6 h and then either maintained in complete medium (lanes 3 and 7) or cultured again in low serum medium (lanes 4 and 8). Cellular extracts were prepared as before and analysed for E2F protein complexes 4). This data suggests that one possibility for the presence of the S-phase E2F complex in serum starved v-mos-transformed cells is that these cells lack a mechanism to disassemble this complex.
v-mos-transformed cells have increased E2F transcriptional activity
It has been proposed that the G1-speci®c p130-E2F complex has a negative regulatory eect on gene activation by E2F (Vairo et al., 1995) . Since v-mostransformed cells lack this E2F complex, we investigated whether E2F activity was higher in v-mostransformed cells than in the parental cells that can express this inhibitory complex. This study utilized the Ad5 wildtype E2 promoter CAT (chloramphenicolacetyl-transferase) or mutant E2-CAT reporter constructs as well as a control plasmid carrying the neomycin-resistance gene. Stable populations of cells were selected that had been co-transfected with either a wildtype or mutant E2-CAT reporter construct and the control plasmid. These populations were synchronized and E2F activity was measured in G0 and S-phase ( Figure 4 ). Normal NIH3T3 cells did not show any detectable E2F speci®c activity above the background levels seen with the mutant controls during G0 arrest, consistent with the presence of negative regulatory complexes. However, 16 h after the release from low serum the cells showed a twofold increase in E2F activity above levels seen with G0 extracts and mutant controls. The serum starved v-mos-transformed cells had ®vefold higher levels of E2F activity than that seen in serum starved NIH3T3 cells. In addition, there was no additional increase in E2F activity in the 121 mos cells during S-phase, consistent with the observation that E2F complexes do not change through the cell cycle in these transformed cells.
Many genes required for the G1/S transition are partially controlled at the transcriptional level by E2F. Transcription of the cdc2 gene has been shown to be regulated by E2F (Dalton, 1992; DeGregori et al., 1995) , and it has been shown that serum starved v-mostransformed cells contain elevated levels of cdc2 transcript (Rhodes et al., unpublished) . This is consistent with increased E2F activity in v-mostransformed cells. In addition, we found that during serum starvation arrest, cyclin A, DHFR, and E2F-1 mRNAs, which are all regulated by E2F (Blake and Azizkhan, 1989; Henglein et al., 1994; Johnson et al., 1994; Mudryj et al., 1990) , and are normally downregulated in untransformed NIH3T3 cells, are also increased in the serum starved 121 mos cells (data not shown).
AP-1 binding is increased in v-mos-transformed cells
We were interested in determining whether the deregulation of E2F DNA binding we observed in vmos-transformed cells could be extended to other transcription factor complexes. Previously, it has been shown that transformation by v-mos leads to activation of the MAP kinase pathway, ultimately leading to increased activation of AP-1 (Liu et al., 1994; Mansour et al., 1994) . However, these studies did not investigate AP-1 DNA binding complexes or the regulation of binding of these complexes through the cell cycle. We show that serum starved NIH3T3 cells contained low levels of AP-1 binding activity ( Figure 5 , lane 1), which increased 3 h after the cells were stimulated to reenter G1 ( Figure 5, lane 2) . However, as was seen for E2F, AP-1 DNA binding activity was high in serum starved v-mos-transformed cells ( Figure 5 , lanes 4 and 6), in contrast to parental NIH3T3 cells or cells transformed by the tpr-met oncogene ( Figure 5, lanes 1 and 8) . Studies investigating which members of the fos/jun family are responsible for this increase in binding activity are currently underway.
Discussion
This report presents several important observations relating transformation by the v-mos oncogene to alterations in gene regulation. It was shown that vmos-transformation can lead to a deregulation of E2F transcription factor complexes. First, we were unable to detect, in either 121 mos or 422 mos cells, the negative-regulatory p130-E2F complex that is normally formed during G0 and G1 in untransformed cells (Cobrinik et al., 1993; Schwarz et al., 1993) . In addition, two E2F complexes containing p107, cdk2, and either cyclin E or cyclin A that are normally only found after progression through the G1/S transition (Devoto et al., 1992; Lees et al., 1992) were found to be constitutively expressed in v-mos-transformed cells. Second, v-mos-transformed cells maintained a higher level of E2F activated transcription and E2F regulated ) or mutant ( ) -CAT plasmid constructs were serum starved for 48 h and then refed and cultured for 16 h. Cells were harvested, protein extracts prepared, samples normalized for protein content, and extracts assayed for chloramphenicol-acetyltransferase activity. The amount of radioactivity in the acetylated chloramphenicol was quantitated by liquid scintillation counting. The results shown are the average of three experiments mRNAs during serum deprivation-induced arrest as compared to untransformed cells. Finally, in addition to changes in E2F complexes, an elevation of AP-1 DNA binding complexes were also observed in serum starved v-mos-transformed cells.
The major breakthrough in understanding the function of the mos protein kinase was the elucidation of its involvement in the activation of MPF in oocytes (Sagata et al., 1988 (Sagata et al., , 1989a and its role as a component of cytostatic factor (CSF) (Masui and Market, 1971; Sagata et al., 1989a,b) . More recent studies have led to the identi®cation of MAPKK as an important substrate for the mos kinase in both meiotic maturation, CSF arrest, and transformation (Mansour et al., 1994; Nebreda and Hunt, 1993; Nebreda et al., 1993; Posada et al., 1993) . These studies also showed that an important, indirect, downstream event of the MAPKK activation was an increase in AP-1 transcriptional activation (Liu et al., 1994; Mansour et al., 1994) . We have now demonstrated that in addition to AP-1, E2F transcription is also increased as a consequence of v-mos-transformation.
E2F is involved in both the positive and negative regulation of gene transcription Lamb et al., 1993; Mudryj et al., 1990; Weintraub et al., 1992) , and its activity is in¯uenced by its interaction with other cellular components. Normally during G0/G1, E2F associates speci®cally with the Rbrelated p130 protein (Cobrinik et al., 1993) . It is known that E2F4 is the E2F family member that predominantly associates with p130, and more importantly, p130 can suppress E2F4-mediated transactivation (Vairo et al., 1995) . This suggests that the role of the G1-speci®c p130-E2F complex is to negatively regulate gene transcription and cell growth. Indeed, introduction of p130 into tumor cell lines results in suppression of cell growth (Claudio et al., 1994) . Loss of the p130-E2F complex in v-mos-transformed cells may be an important step in allowing alteration of cell cycle control and conferring a growth advantage to these cells. Preliminary data suggest that p130 protein levels themselves are decreased in v-mos-transformed cells, and we are currently investigating the cause of this and the lack of p130-E2F complex formation in these cells.
As normal cells progress from G0 through the G1/S transition, the p130-E2F complex is dissociated and replaced by two new E2F complexes that both contain p107 (Devoto et al., 1992; Lees et al., 1992) . The expression of these complexes during the transition to S-phase suggests that they play an important role in the control of genes required for the progression from G1 to S-phase. We have identi®ed the presence of both of these complexes in v-mos-transformed cells, not only during S-phase but constitutively throughout the cell cycle. Other studies have shown that p107 also associates with E2F4 (Beijersbergen et al., 1994; Ginsberg et al., 1994) , and that p107 may inhibit E2F4 transactivation (Ginsberg et al., 1994) . This seems contradictory to our data whereby the constitutive expression of p107-E2F complexes results in a growth advantage of v-mos-transformed cells as well as an increase in E2F-mediated transcription. There are two possible explanations for this disparity. One is that the activity of the p107-E2F complexes inhibits negative growth regulatory genes. Therefore, the increased expression of these complexes may inhibit the expression of genes involved in preventing cell cycle progression. Alternatively, although p107 can inhibit E2F4-mediated gene transactivation (Ginsberg et al., 1994) , its eects when coupled with cyclin A and cyclin E/cdk2 kinase complexes have not been demonstrated. Our transcription assays were conducted in cells maintaing the endogenous complement of E2F family members without the forced over-expression of one family member over another. In addition, these p107-E2F complexes are not down-regulated as v-mostransformed cells enter into G1, as they are in untransformed cells. This suggests that the mechanism that allows dissociation of this complex is also disrupted as part of the transformation process in these cells. The mechanism responsible for this complex dissociation is currently unknown, but may play an important role in normal cell cycle/division control.
Finally, we have shown that v-mos-transformation leads to the increased expression of E2F-regulated genes during serum starvation. This has been observed previously in a study of thymidine kinase expression in normal versus transformed cells (Hengstschlager et al., 1994) . In that study, it was shown that transformation resulted in an increase in the expression of thymidine kinase mRNA (Hengstschlager et al., 1994) , an E2F-regulated gene (Dou et al., 1992) . E2F1 mRNA is increased in v-mos-transformants. Johnson et al. (1994) showed the deregulated expression of the G1 cyclins resulted in activation of the E2F1 promoter, which in -NIH3T3 ss -+ 3h -+16h -422mos ss -+ 3h -121mos ss -+ 3h -tpr-met ss -+ 3h -422mos ss + comp AP-1 -Probe -1 2 3 4 5 6 7 8 9 10
Figure 5 AP-1 binding complexes. Gel shift analysis using an AP-1 consensus sequence probe is shown for NIH3T3 (lanes 1 ± 3), 422 mos (lanes 4 ± 5), 121 mos (lanes 6 ± 7), and tpr-met-1 cells (lanes 9 ± 10). Cells were either serum starved (ss) or serum starved and then refed for the times indicated above each lane. Lane 10 is the same as lane 4 except that 100-fold excess cold probe was added as a competitor of binding turn, can autoregulate its own expression. Therefore, the deregulation and activation of cyclin/cdks in v-mostransformed cells (Rhodes et al., unpublished) could be directly involved in increasing E2F1 expression and the expression of E2F regulated genes. The increase in E2F1 expression could also be directly responsible for the increase activation of E2F-CAT activity in our assays. Furthermore, E2F1 overexpression has been shown to inhibit entry into quiescence (Johnson et al., 1993) . This may help explain why serum starved v-mostransformed cells enter what appears to be a`pseudo' quiescent state, where DNA synthesis is inhibited, but the cells maintain cell cycle regulatory complexes that are similar to cells undergoing cell division (Rhodes et al., unpublished) . The eects of v-mos-transformation on E2F complexes appears to be somewhat speci®c. We did not observe the complete down-regulation of the p130-E2F complex in trp-met or v-H-ras transformants. It is surprising that since ras has been shown to also be involved in activation of the MAP kinase pathway (Leevers and Marshall, 1992) , these cells did not resemble the v-mos-transformed cells with respect to E2F changes. This may suggest that alteration of E2F activation represents a unique aspect of mos function that is independent of its aect on the MAP kinase pathway. A second possibility is that our v-H-rastransformed cells, which appear morphologically less transformed than the v-mos-transformed cells, have not undergone the same E2F deregulation which could be an independent event in the transformation process. We are currently investigating other NIH3T3 transformed lines to address this question of speci®city. Analysis of other transformed cells indicates that the presence of the S-phase E2F complexes during G1 is not a general feature of transformation. Other transformed cells such as HeLa, 293 and cos cells, and particularly cells that are transformed by adenovirus E1A, SV40 T antigen or papillomavirus E7 do not have any E2F complexes, so the presence of cyclin A/E2F complexes during G1 in v-mos-transformed cells is not simply a consequence of transformation. Interestingly, we have observed similar properties of E2F complex deregulation in immortal but untransformed ®broblasts from individuals with Li-Fraumeni syndrome (data not shown). This suggests that the consequences of immortalization and transformation events leading to alteration of E2F complexes and E2F activity could be important in the development of cancer.
Materials and methods
Cells and culture conditions
Parental NIH3T3 cells and two independent v-mos (strain m1)-transformed NIH3T3 cell lines, 121 mos and 422 mos (Rhodes et al., 1994) , were cultured in Dulbecco's Modi®ed Eagle Medium (DMEM) with 10% calf serum (Gibco/ BRL, Gaithersburg, MD) in a humidi®ed chamber at 378C and 5% CO 2 . tpr-met-transformed NIH3T3 cells were from Drs George Vande Woude and Ira Daar, ABL-BRP, and v-H-ras-transformed NIH3T3 cells were from Dr Donald Blair, NCI. The inducible sense and anti-sense mos cells were developed and treated as described (Rhodes et al., unpublished) . Cells were grown arrested by culturing in medium with serum levels reduced to 0.5% for the parental NIH3T3 cells, or to 0% for the transformed cell lines for 48 h.
Quantitation of labeling index and¯ow cytometric analysis
For cell labeling experiments, cells were plated at the same density as cells that were plated for cell extracts in medium containing 2 mCi/ml [ 3 H]thymidine. After the labeling period, cells were rinsed with phosphate buered saline (PBS), ®xed with 50% methanol : acetic acid (4 : 1) for 15 min, followed by ®xing in methanol : acetic acid (4 : 1) for an additional 15 min. Dishes were rinsed with H 2 O, coated with NTB-2 bulk emulsion (Kodak, Rochester, NY) stored at 48C for 4 days then developed and ®xed. The per cent labeling index (%LI) was scored as the number of labeled nuclei/total number of nuclei for at least 1000 nuclei per dish.
For analysis of cellular DNA content by¯ow cytometry, trypsinized cells were ®xed in methanol : PBS (2 : 1) and stored at 48C. Cells were treated with RNase and propidium iodide according to instructions contained in the cellular DNA¯ow cytometric analysis reagent set (Boehringer Mannheim) and analysed using a Becton-Dickinson FACSCAN¯uorescence activated cell scanner. Data acquisition and analysis were performed using Cell®t (Becton-Dickinson) and Maccycle (Phoenix Flow Systems, Inc.) programs, respectively.
Gel shift assays
Whole cell extracts for gel shift analysis were prepared as described previously (Mudryj et al., 1991) . Following two rinses with cold PBS, the cells were scraped and pelleted, excess PBS was removed, and cell pellets were frozen at 7808C. Prior to the extraction, cold lysis buer (containing the protease inhibitors, PMSF, leupeptin, Pefabloc (Boehringer Mannheim), aprotinin, and pepstatin, and the phosphatase inhibitors, sodium¯uoride, and sodium orthovanadate; all reagents were obtained from Sigma Chemical Co. unless otherwise speci®ed), was added to each frozen pellet, and the cells were thawed on ice in the presence of these inhibitors. Binding reactions were incubated at room temperature (RT) for 20 min prior to loading on 4% acrylamide gels that were run for 2 h at 280 volts at 48C. AP-1 gel shift analyses were performed similarly to E2F gel shift assays using a 110 bp probe containing the AP-1 consensus sequence, 5'-TGAGTCA-3'.
Immunoprecipitation of E2F associated binding activity
For immunoprecipitation from whole cell extracts, 50 mg of protein was precleared by the addition of either 30 ml of protein A-or protein G-sepharose, for 1 h. Beads were pelleted and supernatant was transferred to a new tube containing antibody. Rb and p53 antibodies were obtained from Oncogene Science Inc. Rabbit polyclonal antibodies speci®c to human CDK2 and cyclin D1 were procured from Upstate Biotechnology Inc. Cyclin A, cyclin E and p107 antibodies were provided by Drs J Schwartz, J Roberts and N Dyson, respectively. Following antibody binding (16 h), protein A-or protein G-sepharose beads were added for 1 h, pelleted, and pellets were washed four times with 16gel shift buer (Mudryj et al., 1990) containing 3 mg/ml BSA. Beads were resuspended in 5 ml of shift buer and 0.5 ml of 8% deoxycholate was added to dissociate complexes (10 min, RT). The supernatant was removed, 2 ml of 10% NP40 was added, and the entire supernatant was assayed for the presence of E2F as described previously (Mudryj et al., 1991) .
E2F-mediated transfection assay
2610
5 NIH3T3 or 121 mos cells were plated per 100 mm dish. The following day, cells were refed and transfected overnight with 9 mg of E2-CAT plasmid DNA, or a mutant E2-CAT plasmid DNA, plus 1 mg of plasmid DNA containing the beta-actin promoter upstream of the neomycin-resistance gene (plasmids provided by Dr J Nevins), by the calcium phosphate transfection method (Lester et al., 1980; Wigler et al., 1978) . The next day, cells were washed with serum free medium and refed with fresh medium containing 10% calf serum. Two days after transfection, 800 mg/ml G418 was added to the medium for selection. Stable populations were selected and subjected to serum starvation and release as described. Cells were scraped, lysed by freeze-thawing, extracts were normalized for protein content, and assayed for CAT activity as previously described (Gorman et al., 1982) . Radioactive counts were quantitated both by phosphorimager analysis and liquid scintillation counting.
